Med Life SA traded at 11.50 this Friday August 21st, decreasing 0.28 or 2.38 percent since the previous trading session. Looking back, over the last four weeks, Med Life lost 5.74 percent. Over the last 12 months, its price rose by 38.39 percent. Looking ahead, we forecast Med Life SA to be priced at 11.49 by the end of this quarter and at 10.65 in one year, according to Trading Economics global macro models projections and analysts expectations.
Med Life SA is a Romania-based company engaged in the healthcare industry. Its portfolio of medical services includes clinical and laboratory testing services, medical imaging, reproductive medicine, hospital admission and surgical interventions, among others. Med Life SA offers treatments in the areas of dental, orthopedics and traumatology, gynecology, plastic and reconstructive surgery, oncology and surgical oncology, infertility and assisted reproduction, medical genetics, and medical checkups, spinal, pediatric and genitourinary surgeries, among others. The Company operates over 10 clinics, around five hospitals, an ambulatory facilities, over 15 test laboratories and around five maternity hospitals, among others.